Singular Genomics Systems, Inc. (OMIC)

Market Cap	49.11M
Revenue (ttm)	2.67M
Net Income (ttm)	-86.32M
Shares Out	2.51M
EPS (ttm)	-34.77
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,998
Open	20.18
Previous Close	19.97
Day's Range	19.50 - 20.23
52-Week Range	5.34 - 23.41
Beta	1.83
Analysts	Hold
Price Target	10.75 (-45.01%)
Earnings Date	Nov 12, 2024

About OMIC

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: May 27, 2021
• Employees: 255
• Stock Exchange: NASDAQ
• Ticker Symbol: OMIC
• Website: https://www.singulargenomics.com

Financial Performance

In 2023, Singular Genomics Systems's revenue was $2.91 million, an increase of 280.52% compared to the previous year's $765,000. Losses were -$94.82 million, 4.34% more than in 2022.

Analyst Forecast

According to 2 analysts, the average rating for OMIC stock is "Hold." The 12-month stock price forecast is $10.75, which is a decrease of -45.01% from the latest price.

Price Target

$10.75

(-45.01% downside)

Analyst Consensus: Hold